EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Molecular basis for the activation of the bitter taste receptor TAS2R14 by Ritonavir

Jiao Wen iD, Xinyi Ma, Xinyi Zhou, R Charles Kissell, Yongcheng Lu iD, Yukyoung Kim, Young Seo Lee, Alice Lee, Shurui Chen, Keman Xu, Leigh D Plant iD, Meng Cui iD

PLOS One · 2025

DOI: 10.1371/journal.pone.0332704 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS One, 2025. Verfasst von Jiao Wen und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Sciences and the Center for Drug Discovery, School of Pharmacy and Pharmaceutical Sciences, Bouvé College of Health Scie…. Hauptthemen laut MEDLINE: Receptors, G-Protein-Coupled, Ritonavir, Taste. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIDCD NIH HHS, National Institute on Deafness and Other Communication Disorders.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Ritonavir is a protease inhibitor used in combination with other antiretroviral drugs to treat HIV, especially in children. It enhances the effectiveness of these drugs by inhibiting the cytochrome P450-3A4 enzyme, thereby increasing their bioavailability. Ritonavir is also being investigated for cancer treatment due to its mechanism of action. However, its intense bitterness, particularly in liquid formulations, can be intolerable for some children. This bitterness is attributed to its activation of bitter taste receptors, including TAS2R14 (also named T2R14), as demonstrated in our previous study. In this study, we utilized molecular modeling, site-directed mutagenesis, and cell-based calcium mobilization assays to characterize the key residues involved in TAS2R14 activation by ritonavir. Eight critical residues for ritonavir interacting with the receptor were discovered. The results indicate two potential binding sites for ritonavir in TAS2R14 receptor, including orthosteric and allosteric sites. These findings can be useful for developing bitter blockers targeting TAS2R14 to eliminate or reduce the bitter taste of ritonavir.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Receptors, G-Protein-CoupledRitonavirTasteHumansTaste Receptors, Type 2HEK293 CellsBinding SitesMutagenesis, Site-DirectedModels, MolecularCalcium

Substanzen

Receptors, G-Protein-CoupledRitonavirTaste Receptors, Type 2Calcium

Autor:innen und Institutionen

  • Department of Pharmaceutical Sciences and the Center for Drug Discovery, School of Pharmacy and Pharmaceutical Sciences, Bouvé College of Health Sciences, Northeastern University, Boston, Massachusetts, United states of…

ORCID-Profile: Jiao Wen, Yongcheng Lu, Leigh D Plant, Meng Cui

Förderung

  • NIDCD NIH HHS
  • National Institute on Deafness and Other Communication Disorders

Zitieren

APA

Wen, J., Ma, X., Zhou, X., Kissell, R. C., Lu, Y., Kim, Y., Lee, Y. S., Lee, A., Chen, S., Xu, K., Plant, L. D., & Cui, M. (2025). Molecular basis for the activation of the bitter taste receptor TAS2R14 by Ritonavir. PLOS One. https://doi.org/10.1371/journal.pone.0332704

Vancouver

Wen J, Ma X, Zhou X, Kissell RC, Lu Y, Kim Y, et al. Molecular basis for the activation of the bitter taste receptor TAS2R14 by Ritonavir. PLOS One. 2025. doi:10.1371/journal.pone.0332704

BibTeX
@article{Wen2025,
  author = {Wen, Jiao and Ma, Xinyi and Zhou, Xinyi and Kissell, R Charles and Lu, Yongcheng and Kim, Yukyoung and Lee, Young Seo and Lee, Alice and Chen, Shurui and Xu, Keman and Plant, Leigh D and Cui, Meng},
  title = {Molecular basis for the activation of the bitter taste receptor TAS2R14 by Ritonavir},
  journal = {PLOS One},
  year = {2025},
  doi = {10.1371/journal.pone.0332704}
}
Kostenlos starten →